| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Nagata and Company Inc.
|
16.789m | 40.33% | +600.000 | Apr 17 2026 |
| 2 |
Sumitomo Mitsui DS Asset Management Company, Limited
|
2.302m | 5.53% | +427.300k | Nov 28 2025 |
| 3 |
Asset Management One Co., Ltd.
|
2.100m | 5.04% | +1.861m | Dec 15 2025 |
| 4 |
Nagata (Takahisa)
|
1.900m | 4.56% | -60.000k | Sep 30 2025 |
| 5 |
Medipolis Medical Research Institute General Incorporated Association
|
1.474m | 3.54% | — | Sep 30 2025 |
|
1
Nagata and Company Inc.
|
40.33%
16.789m
|
|
2
Sumitomo Mitsui DS Asset Management Company, Limited
|
5.53%
2.302m
|
|
3
Asset Management One Co., Ltd.
|
5.04%
2.100m
|
|
4
Nagata (Takahisa)
|
4.56%
1.900m
|
|
5
Medipolis Medical Research Institute General Incorporated Association
|
3.54%
1.474m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 59.01% of Shin Nippon Biomedical Laboratories,ltd., with Nagata and Company Inc. the biggest at 40.33%, followed by Sumitomo Mitsui DS Asset Management Company, Limited (5.53%) and Asset Management One Co., Ltd. (5.04%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


